Genetics

Researchers found a sharp, synchronized decline across health metrics five months before a colleague’s death. The findings suggest wearables could help identify cardiovascular risk earlier.

Stanford Medicine experts explain how biological age differs from chronological age, why test results vary, and what the numbers actually mean for your health.

TIGRa, half CRISPR’s size, fits in viral vectors to boost protective genes. Its compact design could enable gene therapies throughout the body.

Researchers at Stanford Medicine developed a tool called the Ribo-Tweezer to pluck individual components out of a mature ribosome, finding a surprising role for a protein called RACK1.

Cy Chittenden biked 2,850 miles across America. His DNA is part of a Stanford study investigating the genetics of elite athlete endurance to inform longevity research and treatment strategies.

Research across three continents indicates that geography and ethnicity influence biological processes, aging, and disease risk.

An antibody-based approach for Fanconi anemia replaces traditional toxic conditioning with targeted therapy, allowing safe restoration of blood and immune function without chemotherapy or radiation.

New research suggests that certain genetic variants can decrease the ability of GLP-1 diabetes drugs to regulate blood sugar – a mysterious phenomenon known as GLP-1 resistance.

A “reverse translation” technique converts protein sequences into DNA, enabling unprecedented detection sensitivity.

Pediatrics Assistant Professor Agnieszka Czechowicz explains an innovative trial using maternal cells to treat Fanconi anemia in utero.